IFN‐γ‐Induced CD317 Tethers Extracellular Vesicles to Mesenchymal Stromal Cells Interfering With Immune Modulation
Journal of Extracellular Vesicles · 2025
DOI: 10.1002/jev2.70155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2025. Verfasst von Anton Selich und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells, Interferon-gamma, Antigens, CD. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, REBIRTH Center for Translational Regenerative Medicine.
Abstract (Originalsprache)
In spite of the numerous clinical trials conducted on mesenchymal stromal cells and their extracellular vesicles (MSC‐EVs) across a wide range of diseases, the field faces challenges in reaching a consensus on crucial parameters such as source, marker definition, and culture conditions, adding to heterogeneous efficiencies. Nevertheless, there is widespread acceptance of the pro‐inflammatory activation of MSCs with IFN‐γ and TNF‐α to enhance immune modulation. Our study highlights the impact of activation duration on MSC‐EV‐mediated immune modulation of macrophages. Extended activation periods (24 h) revealed elevated levels of IFN‐γ‐induced CD317 on the MSC surface. CD317 is known to tether enveloped viral particles to the cell membrane, impeding viral diffusion and spread. We demonstrated the accumulation of EVs on the MSC cell surface following activation or lentiviral CD317 overexpression. In contrast, CD317 knockdown eliminated the enrichment of EVs on the cell surface, significantly enhancing the MSC‐EV‐mediated immune modulation of macrophages. Considering the pivotal role of IFN‐γ in MSC immune modulation and its inevitable contact in patients, our findings propose CD317 as a potential modulator of MSC‐based therapy efficacy in clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
- Biochemistry and Tumor Biology Lab, Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany.
- Institute of Functional and Applied Anatomy, Research Core Unit Electron Microscopy, Hannover Medical School, Hannover, Germany.
- CCC-MV and Department of Internal Medicine C, University Medicine Greifswald, Greifswald, Germany.
- Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany.
- Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Anton Selich
Förderung
- Deutsche Forschungsgemeinschaft
- REBIRTH Center for Translational Regenerative Medicine
Zitieren
APA
Selich, A., Weisskoeppel, L., Hass, R., Hegermann, J., Schwarzer, A., von Kaisenberg, C., Schambach, A., & Rothe, M. (2025). IFN‐γ‐Induced CD317 Tethers Extracellular Vesicles to Mesenchymal Stromal Cells Interfering With Immune Modulation. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70155
Vancouver
Selich A, Weisskoeppel L, Hass R, Hegermann J, Schwarzer A, von Kaisenberg C, et al. IFN‐γ‐Induced CD317 Tethers Extracellular Vesicles to Mesenchymal Stromal Cells Interfering With Immune Modulation. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70155
BibTeX
@article{Selich2025,
author = {Selich, Anton and Weisskoeppel, Luisa and Hass, Ralf and Hegermann, Jan and Schwarzer, Adrian and von Kaisenberg, Constantin and Schambach, Axel and Rothe, Michael},
title = {IFN‐γ‐Induced CD317 Tethers Extracellular Vesicles to Mesenchymal Stromal Cells Interfering With Immune Modulation},
journal = {Journal of Extracellular Vesicles},
year = {2025},
doi = {10.1002/jev2.70155}
}
EUVIMED